What Should Diabetic Patients Do About Urinary Incontinence?
Aug 26, 2022
Source: Cainiu Health
Dr. Pan Yongyuan
Introduction
Diabetic patients with urinary incontinence may use antihyperglycemic medications under the guidance of a physician; commonly prescribed agents include metformin extended-release tablets and dapagliflozin tablets. In addition to glycemic control, treatment for urinary incontinence in diabetic patients often involves neuroregenerative medications, such as nerve growth factor and mecobalamin, or alternatively, epalrestat tablets or alpha-lipoic acid tablets.
Urinary incontinence in diabetic patients can be managed through blood glucose control, nerve repair, and other approaches.
Urinary incontinence in diabetic patients is commonly caused by autonomic neuropathy affecting the urinary and genital systems. The first step is therefore strict glycemic control. Under a physician’s guidance, antihyperglycemic medications—such as metformin extended-release tablets and dapagliflozin tablets—may be prescribed. These agents not only achieve stringent glycemic control but also minimize pronounced fluctuations in blood glucose levels, thereby helping to prevent and treat diabetic neuropathy.
In addition to glycemic control, pharmacologic nerve repair therapy is essential for managing urinary incontinence in diabetic patients. Commonly used neurotrophic agents include nerve growth factor and mecobalamin; alternatively, epalrestat tablets or alpha-lipoic acid tablets may be selected.
During treatment, patients must strictly adhere to their physician’s instructions regarding medication use and undergo regular follow-up visits to monitor disease progression closely. Dietary recommendations include consuming low-glycemic-index vegetables—such as celery, tomatoes, and cucumbers—as well as high-quality protein sources—including fish, milk, and lean meats.
